SSG
EXAS

Summit Securities Group’s Exact Sciences EXAS Stock Holding History

Summit Securities Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,000
Closed -$530K – 631
2020
Q4 		$530K Buy
+4,000
New +$484K 0.04% 339
2013
Q4 		– Sell
-2,600
Closed -$31K – 547
2013
Q3 		$31K Buy
+2,600
New +$33.4K 0.01% 205

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Summit Securities Group's EXAS Position: Q1 2021 in Review

Summit Securities Group sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 4,000 shares — an estimated $530K sold.

Summit Securities Group first reported a position in EXAS in Q3 2013 and held it in 2 quarters. The position peaked at $530K in Q4 2020. 645 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Summit Securities Group reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
  • Summit Securities Group sold 4,000 Exact Sciences shares in Q1 2021, an estimated $530K.
  • Summit Securities Group first reported a position in Exact Sciences in Q3 2013 and held it in 2 quarters.
  • Summit Securities Group's Exact Sciences position peaked at $530K in Q4 2020.
  • 645 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Summit Securities Group's 13F filing for Q1 2021, filed 14 Apr 2021.